NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy Cell Rep Med
CompCorona: A web application for comparative transcriptome analyses of coronaviruses reveals SARS-CoV-2-specific host response Turk J Biol
MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis Nat Cell Biol
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin lymphoma Mol Oncol
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF LEUKEMIA RES
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial Lancet Oncol
Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies Front Immunol
Effects of Mediterranean Diet or Mindfulness-Based Stress Reduction on fetal and neonatal brain development A secondary analysis of a Randomized Clinical Trial (IMPACT BCN) AM J OBSTET GYNECOL